Advertisement
Advertisement
U.S. markets open in 1 hour 6 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Kraig Biocraft Laboratories, Inc. (KBLB)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0600-0.0015 (-2.44%)
At close: 03:59PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0615
Open0.0590
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0573 - 0.0660
52 Week Range0.0500 - 0.1200
Volume3,112,568
Avg. Volume1,313,041
Market Cap57.452M
Beta (5Y Monthly)-0.13
PE Ratio (TTM)N/A
EPS (TTM)-0.0090
Earnings DateAug 10, 2022 - Aug 15, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for KBLB

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • KRAIG BIOCRAFT LABORATORIES INC
    Daily – Vickers Top Insider Picks for 07/06/2022The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
    Rating
    Fair Value
    Economic Moat
    yesterdayArgus Research
View more
  • GlobeNewswire

    Kraig Biocraft Laboratories Introduces New, Enhanced Line of Dragon Silk™ Silkworms for Commercial Production

    ANN ARBOR, Mich., July 06, 2022 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), the biotechnology company focused on the development and commercialization of spider silk, announces that it has produced several new lines of larger hybrid Dragon SilkTM silkworms for its production operations in Vietnam. These new breeds of silkworms were explicitly created for large-scale production. With a larger cocoon and longer silk filament, these optimized Dra

  • GlobeNewswire

    Kraig Biocraft Laboratories Takes Next Step in Launching Spydasilk™ Apparel Brand

    ANN ARBOR, Mich., June 27, 2022 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), the biotechnology company focused on the development and commercialization of spider silk, announces that, in collaboration with its joint venture partner, Kings Group, the Company has selected a high-quality garment manufacturer to produce Spydasilk'sTM first apparel line. Over the course of multiple meetings between Kraig Labs, Kings Group, and the garment manufactur

  • GlobeNewswire

    Kraig Biocraft Laboratories Subcontractor Pilot Production has achieved required Spider Silk Production Levels for the Spydasilk™ Apparel Launch

    Kraig Labs Launches the Critical Next Phases of its Business Plan, Expanded Recombinant Spider Silk Production in Collaboration with Third-Party ContractorsHO CHI MINH CITY, Vietnam, June 21, 2022 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), the biotechnology company focused on the development and commercialization of spider silk, announces the completion of its third-party pilot production. As a result of this highly successful program, Kraig

Advertisement
Advertisement